1. Home
  2. Analysis
  3. Ginger
  4. Cataract

Ginger and Cataract - a phase IV clinical study of FDA data

Summary:

Cataract is reported as a side effect among people who take Ginger (ginger), especially for people who are female, 60+ old, also take Vitamin D3, and have Osteopenia.

The phase IV clinical study analyzes which people have Cataract when taking Ginger. It is created by eHealthMe based on reports of 2,278 people who have side effects when taking Ginger from the FDA, and is updated regularly.

What is Ginger?

Ginger has active ingredients of ginger. It is often used in nausea. eHealthMe is studying from 2,449 Ginger users. Check the latest studies of Ginger.

What is Cataract?

Cataract (clouding of the lens inside the eye) is found to be associated with 1,892 drugs and 2,131 conditions by eHealthMe. Check the latest studies of Cataract.

On Jul, 14, 2026

2,278 people reported to have side effects when taking Ginger.
Among them, 29 people (1.27%) have Cataract.

Could Ginger cause Cataract?

Among these 29 people:

What is the gender of people who have Cataract when taking Ginger? *

  • female: 82.14 %
  • male: 17.86 %

What is the age of people who have Cataract when taking Ginger? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Ginger? *

  1. Acetaminophen: 12 people, 41.38%
  2. Vitamin D3: 12 people, 41.38%
  3. Calcium Citrate: 8 people, 27.59%
  4. Epinephrine: 8 people, 27.59%
  5. Miralax: 8 people, 27.59%
  6. Vitamin C: 8 people, 27.59%
  7. Magnesium: 7 people, 24.14%
  8. Lidocaine: 7 people, 24.14%
  9. Proair Hfa: 6 people, 20.69%
  10. Fosamax: 5 people, 17.24%

What are other side effects people have besides Cataract? *

  1. Fatigue (feeling of tiredness): 11 people, 37.93%
  2. Weakness: 8 people, 27.59%
  3. Infusion Site Pain: 8 people, 27.59%
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 6 people, 20.69%
  5. Blood Glucose Increased: 6 people, 20.69%
  6. Urinary Tract Infection: 6 people, 20.69%
  7. Blood Pressure Abnormal: 5 people, 17.24%
  8. Catheter Site Erythema (redness of skin at catheter site): 5 people, 17.24%
  9. Oral Disorder (mouth disease): 5 people, 17.24%
  10. Oral Discomfort (pain or irritation in mouth): 5 people, 17.24%

What are the existing conditions these people have? *

  1. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 5 people, 17.24%
  2. Immune System Disorder: 5 people, 17.24%
  3. Bone Density Decreased: 5 people, 17.24%
  4. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 5 people, 17.24%
  5. Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 17.24%
  6. Immunodeficiency Common Variable: 4 people, 13.79%
  7. Pain: 3 people, 10.34%
  8. Multiple Myeloma (cancer of the plasma cells): 3 people, 10.34%
  9. Prostate Cancer: 3 people, 10.34%
  10. Ovarian Cancer (cancer of ovary): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Ginger and have Cataract?

- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ginger:

Cataract treatments and more:

How severe was Cataract and when was it recovered:

Expand to all the drugs that have ingredients of ginger:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ginger:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cataract:

Browse all the conditions that are associated with Cataract:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ginger (the active ingredients of Ginger) and Ginger (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.